{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T03:31:46Z","timestamp":1794799906982,"version":"4.9.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>\n                    Rhabdomyosarcoma with\n                    <jats:italic toggle=\"yes\">EWSR1\/FUS::TFCP2<\/jats:italic>\n                    fusion is an emerging subtype of rhabdomyosarcoma that rarely arises in skin. It is characterized by spindle and epithelioid morphology, and frequent expression of cytokeratin and anaplastic lymphoma kinase (ALK). We report a case of primary cutaneous rhabdomyosarcoma with\n                    <jats:italic toggle=\"yes\">FUS::TFCP2<\/jats:italic>\n                    fusion in a 59-year-old man who initially presented with an erythematous lesion on the chest that progressed to a mass-forming lesion 6 months before his hospital visit. On examination, an irregularly shaped 12-cm indurated erythematous plaque with a 2-cm multinodular solid mass was observed. Histologic examination revealed sparse infiltration of round cells with minimal atypia within the thickened dermis of the erythematous area, while the mass exhibited fascicular or sheet-like proliferation of atypical spindle and epithelioid cells. Diffuse expression of ALK and cytokeratin, along with partial expression of alpha smooth muscle actin and desmin, raised suspicion of\n                    <jats:italic toggle=\"yes\">ALK<\/jats:italic>\n                    -rearranged mesenchymal neoplasms, including inflammatory myofibroblastic tumor. However, fluorescence in situ hybridization (FISH) failed to detect\n                    <jats:italic toggle=\"yes\">ALK<\/jats:italic>\n                    rearrangements.\n                    <jats:italic toggle=\"yes\">FUS::TFCP2<\/jats:italic>\n                    fusion was identified by RNA sequencing and confirmed by FISH. Additional immunohistochemistry for myogenin and MyoD1 demonstrated myogenic differentiation, leading to the final diagnosis. The patient underwent chemotherapy and surgical resection, followed by radiotherapy, and remains disease free for 8 months postoperatively. This case highlights the diagnostic challenges posed by aberrant ALK expression and the indolent appearance of early stage lesions. Awareness of this rare entity combined with molecular testing is crucial for accurate diagnosis and appropriate management.\n                  <\/jats:p>","DOI":"10.1097\/dad.0000000000003031","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T07:00:10Z","timestamp":1750921210000},"page":"703-708","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Cutaneous Rhabdomyosarcoma With FUS::TFCP2 Fusion: An Emerging Entity That Expands the Differential Diagnosis of ALK-Positive Spindle Cell Neoplasm of the Skin"],"prefix":"10.1097","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8550-5793","authenticated-orcid":false,"given":"Kentaro","family":"Tsuji","sequence":"first","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Togashi","sequence":"additional","affiliation":[{"name":"Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan;"},{"name":"Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan;"},{"name":"Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Baba","sequence":"additional","affiliation":[{"name":"Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan;"},{"name":"Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan;"},{"name":"Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akito","family":"Dobashi","sequence":"additional","affiliation":[{"name":"Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan;"},{"name":"Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan;"},{"name":"Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan;"},{"name":"Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan;"},{"name":"Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Sakiyama","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yui","family":"Hirano-Lotman","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Irie","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Endo","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhide","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Haga","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"key":"R1-20250819","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.anndiagpath.2016.11.005","article-title":"Primary cutaneous spindle cell B cell lymphoma: a report of three cases and review of the literature","volume":"27","author":"Magro","year":"2017","journal-title":"Ann Diagn Pathol."},{"key":"R2-20250819","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/DAD.0000000000002752","article-title":"Primary cutaneous spindle cell B-cell follicle center lymphoma presenting as long-standing plaque of cicatricial alopecia: a case report with a comprehensive review of the literature","volume":"46","author":"Bigotto","year":"2024","journal-title":"Am J Dermatopathol"},{"key":"R3-20250819","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/PAS.0000000000001103","article-title":"ALK expression in angiomatoid fibrous histiocytoma: a potential diagnostic pitfall","volume":"43","author":"Cheah","year":"2019","journal-title":"Am J Surg Pathol."},{"key":"R4-20250819","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1038\/s41379-020-0646-5","article-title":"EWSR1\/FUS-CREB fusions define a distinctive malignant epithelioid neoplasm with predilection for mesothelial-lined cavities","volume":"33","author":"Argani","year":"2020","journal-title":"Mod Pathol."},{"key":"R5-20250819","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00428-021-03140-3","article-title":"Intra-abdominal EWSR1\/FUS-CREM-rearranged malignant epithelioid neoplasms: two cases of an emerging aggressive entity with emphasis on misleading immunophenotype","volume":"480","author":"Agaimy","year":"2022","journal-title":"Virchows Arch."},{"key":"R6-20250819","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/gcc.23038","article-title":"Molecular investigation of ALK-rearranged epithelioid fibrous histiocytomas identifies CLTC as a novel fusion partner and evidence of fusion-independent transcription activation","volume":"61","author":"Georgantzoglou","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"key":"R7-20250819","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00428-019-02676-9","article-title":"The current landscape of rhabdomyosarcomas: an update","volume":"476","author":"Leiner","year":"2020","journal-title":"Virchows Arch."},{"key":"R8-20250819","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/his.14449","article-title":"Evolving classification of rhabdomyosarcoma","volume":"80","author":"Agaram","year":"2022","journal-title":"Histopathology"},{"key":"R9-20250819","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.humpath.2023.12.004","article-title":"Rhabdomyosarcoma: updates on classification and the necessity of molecular testing beyond immunohistochemistry","volume":"147","author":"Dehner","year":"2024","journal-title":"Hum Pathol."},{"key":"R10-20250819","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1177\/10668969221137517","article-title":"Rhabdomyosarcoma with FUS::TFCP2 fusion in the scalp: a rare case report depicting round and spindle cell morphology","volume":"31","author":"Ishiyama","year":"2023","journal-title":"Int J Surg Pathol."},{"key":"R11-20250819","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/cup.14526","article-title":"Cutaneous rhabdomyosarcoma with FUS::TFCP2 fusion: a case report emphasizing early detection","volume":"50","author":"Demirkesen","year":"2023","journal-title":"J Cutan Pathol."},{"key":"R12-20250819","first-page":"1","article-title":"Primary cutaneous rhabdomyosarcoma with EWSR1\/FUS::TFCP2 fusion: four new cases with distinctive morphology, immunophenotypic, and genetic profile","author":"Machado","year":"2024","journal-title":"Virchows Arch"},{"key":"R14-20250819","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/his.14323","article-title":"Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases","volume":"79","author":"Xu","year":"2021","journal-title":"Histopathology"},{"key":"R15-20250819","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41379-019-0323-8","article-title":"A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation","volume":"33","author":"Le Loarer","year":"2020","journal-title":"Mod Pathol."},{"key":"R16-20250819","doi-asserted-by":"crossref","first-page":"100271","DOI":"10.1016\/j.modpat.2023.100271","article-title":"Fusion-driven Spindle cell rhabdomyosarcomas of bone and soft tissue: a clinicopathologic and molecular genetic study of 25 cases","volume":"36","author":"Dehner","year":"2023","journal-title":"Mod Pathol."},{"key":"R17-20250819","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41467-023-44360-2","article-title":"Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions","volume":"15","author":"Sch\u00f6pf","year":"2024","journal-title":"Nat Commun."},{"key":"R18-20250819","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1097\/PAS.0000000000001735","article-title":"Clinicopathologic and genomic characterization of inflammatory myofibroblastic tumors of the head and neck: highlighting a novel fusion and potential diagnostic pitfall","volume":"45","author":"Kerr","year":"2021","journal-title":"Am J Surg Pathol."},{"key":"R19-20250819","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.5858\/arpa.2021-0230-OA","article-title":"Assessment of ALK fusions in uncommon inflammatory myofibroblastic tumors with ALK IHC positivity but FISH-equivocal findings by targeted RNA sequencing","volume":"146","author":"Yao","year":"2022","journal-title":"Arch Pathol Lab Med."},{"key":"R20-20250819","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/path.5053","article-title":"Transcriptomic definition of molecular subgroups of small round cell sarcomas","volume":"245","author":"Watson","year":"2018","journal-title":"J Pathol."},{"key":"R21-20250819","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/his.14833","article-title":"Clinicopathological features of rhabdomyosarcoma with novel FET::TFCP2 and TIMP3::ALK fusion: report of two cases and literature review","volume":"82","author":"Duan","year":"2023","journal-title":"Histopathology"},{"key":"R22-20250819","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.pathol.2019.07.004","article-title":"Lack of clinical activity with crizotinib in a patient with FUS rearranged rhabdomyosarcoma with ALK protein overexpression","volume":"51","author":"Lewin","year":"2019","journal-title":"Pathology"},{"key":"R23-20250819","doi-asserted-by":"crossref","first-page":"e28185","DOI":"10.1002\/pbc.28185","article-title":"The combination of radiotherapy and ALK inhibitors is effective in the treatment of intraosseous rhabdomyosarcoma with FUS-TFCP2 fusion transcript","volume":"67","author":"Brunac","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"R24-20250819","doi-asserted-by":"crossref","first-page":"a006209","DOI":"10.1101\/mcs.a006209","article-title":"EWSR1-TFCP2 in an adolescent represents an extremely rare and aggressive form of intraosseous spindle cell rhabdomyosarcomas","volume":"8","author":"Panferova","year":"2022","journal-title":"Cold Spring Harb Mol Case Stud."},{"key":"R25-20250819","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1177\/10668969221140397","article-title":"Intraosseous spindle cell\/epithelioid rhabdomyosarcoma with TFCP2 rearrangement: a recent recognized subtype with partial response to alectinib","volume":"31","author":"Val\u00e9rio","year":"2023","journal-title":"Int J Surg Pathol."},{"key":"R26-20250819","doi-asserted-by":"crossref","first-page":"e23259","DOI":"10.1002\/gcc.23259","article-title":"Diagnostic and Therapeutic implications of a FUS::TFCP2 fusion and ALK activation in a metastatic rhabdomyosarcoma","volume":"63","author":"Csizmok","year":"2024","journal-title":"Genes Chromosomes Cancer"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000003031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T14:00:37Z","timestamp":1755612037000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000003031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000003031","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"value":"0193-1091","type":"print"},{"value":"1533-0311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,26]]}}}